← Back to list
05.00.86, Remote Electrical Neuromodulation for Migraines
Act
by Dec 31, 2025
Effective date
Jan 1, 2026
Identified
Sep 17, 2026
Summary
Independence Blue Cross has upgraded Remote Electrical Neuromodulation (REN) devices like Nerivio from Experimental/Investigational to Medically Necessary for migraine prevention in adults (18+) and pediatric patients (8-17) who meet specific clinical criteria, including migraine frequency of 6-24 headache days per 28-day period and failure of or contraindication to preventive medications. This policy is effective January 1, 2026, and represents a significant coverage expansion that will allow claims for previously denied devices.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.
What to do
by Dec 31, 2025 · 6 steps
01Billing team must update billing software and claim submission protocols to recognize REN devices (e.g., Nerivio) billed under HCPCS code A4540 as medically necessary rather than experimental/investigational for migraine prevention.
02Providers must document: (1) patient age (18+ or 8-17), (2) ICHD-3 diagnosis confirmation, (3) headache frequency of 6-24 days per 28-day period over preceding 3 months, and (4) one qualifying criterion (failed/contraindicated preventive meds, pregnancy/breastfeeding, overuse headache risk, or drug-drug interactions).
03Update claim templates and prior authorization workflows to require this documentation.
04For continued coverage, track compliance and clinical benefit documentation.
05Failure to include required documentation will result in claim denials.
06Inform providers that acute migraine treatment and prevention outside these criteria remain experimental/investigational and are NOT covered.
Codes mentioned
A4540G43.001G43.009G43.011G43.019G43.101G43.109G43.111G43.119
Original notice
05.00.86, Remote Electrical Neuromodulation for Migraines
medpolicy.ibx.com · Always check the source before changing claims.
Related changes
See all Independence Blue Cross changes →MA05.071, Remote Electrical Neuromodulation for MigrainesMediumEffective Jan 1, 2026 · Medical PolicyMA05.071, Remote Electrical Neuromodulation for MigrainesLowEffective Jan 1, 2026 · Medical Policy05.00.86, Remote Electrical Neuromodulation for MigrainesLowEffective Jan 1, 2026 · Medical Policy07.00.01n, Biofeedback TherapyMediumEffective Jul 1, 2024 · Medical PolicyBrowse every Independence Blue Cross change in the policy list